{
  "anumber": "A28708181",
  "id": "A28708181_0036",
  "page_index": 36,
  "resources": {
    "full_jpg": "https://dctn4zjpwgdwdiiy5odjv7o2se0bqgjb.lambda-url.us-east-1.on.aws/iiif/3/og-2023-kc-nara_A28708181_0036/full/max/0/default.jpg"
  },
  "fields": {
    "doctype": {
      "ms_doctype_v1": "form"
    },
    "years": {
      "ms_years_nlp_v1": [
        2023
      ]
    }
  },
  "is_g325a": false,
  "is_cert_naturalization": false,
  "full_text": "Screened by NARA, 8/22/2023 AM 3208 TERADRAM JANOITAMASTVI (E) AMACALIAO (OL OR HRARDBURT a 10811 01800 AD 39 ATMAB SERODIAGNOSIS OF ACUTE VIRAL HEPATITIS Test result: Interpretation: HBsAg HBsAb HBcAb HAV-lgM + Recent acute hepatitis A infection Early acute type B hepatitis 8998 + + Acute or chronic type B hepatitis + + Chronic or acute type B hepatitis Recovery from or past infection of type B hepatitis Remote past infection or immediate recovery phase or low level carrier of type B hepatitis Remote past infection or immunization with HBsAg Recent probable hepatitis A infection and probable chronic type B hepatitis Possible non-A non-B hepatitis infection. other viral infection, or liver toxin ANTI-NUCLEAR ANTIBODY, SERUM Four distinguishable patterns of nuclear fluorescence have been described. The following table indicates the pattern, the antigen associated with the pattern of fluorescence, and the incidence of disease; systemic lupus erythematosus (SLE), mixed connective tissue disease (MCTD), rheumatoid arthritis (RA), chronic active hepatitis (CAH), progressive systemic sclerosis (PSS), and normals. INCIDENCE (PERCENT) Pattern Antigen SLE MCTD RA CAH PSS Normal Peripheral (rim) ssDNA 90 20-60 20-60 dsDNA 40-60 3-9 1% Diffuse (homogenous) dRNP 98 15-40 40 15-40 Speckled RNP 50 100 1% SM 30 1% Nucleolar RNA 20 Y900 TRAHO"
}